# Cancer Prevention and Control

> **NIH NIH P30** · INDIANA UNIVERSITY INDIANAPOLIS · 2024 · $68,494

## Abstract

ABSTRACT, Cancer Prevention and Control (CPC) Research Program
The overall goals of the CPC Program, which are aligned with the Indiana University Simon Comprehensive
Cancer Center (IUSCCC) Strategic Plan and guided by the unique needs and priorities of our catchment area,
are to 1) decrease the incidence of cancer and 2) decrease the impact of cancer diagnoses and treatments on
the lives of survivors and their families. Serving these goals, the CPC Program focuses its work on two themes,
each with two aims: Theme 1) Risk Reduction and Early Detection (includes Aims 1 and 2), and Theme 2)
Survivorship and Symptom Science (includes Aims 3 and 4). Within each theme, CPC members address two
aims related to the identification of risk factors and the development and testing of interventions. Theme 1 is
focused on risk reduction and early detection, discovering genetic, biological, social, and behavioral risk factors
that contribute to the development of major cancers affecting the people of Indiana (Aim 1) and developing and
evaluating innovative models and interventions that reduce cancer risk, improve screening, and increase early
detection of cancers (Aim 2). Theme 2 is focused on survivorship and symptom science, identifying genetic,
biological, social, and pharmacogenomic risk factors associated with cancer symptoms and treatment-related
toxicities (Aim 3) and developing and testing interventions to reduce treatment-related symptoms and enhance
survivorship for cancer patients and their families (Aim 4). Efforts to include underrepresented populations in
research, to reduce disparities in cancer care delivery, and to improve health equity are integrated across all four
aims. In 2018, the Program was evaluated as “Outstanding.” Since the prior review, CPC membership has nearly
doubled from 37 (in 2018) to 63 members: 34 Full and 29 Associate Members, representing 24 Departments
and seven Schools on the campuses of Indiana University at Indianapolis, Indiana University at Bloomington,
and Purdue University. Since the last review, CPC funding has grown from $6.3M to $10.8M in peer-reviewed
direct cost funding, representing a 71% increase. Current NCI direct cost funding is $5.1M compared to $2.8M
reported in 2018, representing an 85% increase. Over the past funding period, CPC members authored 821
publications, up from 409 in 2018, representing a 100% increase. Of these, 25% are from intra-programmatic
collaborations, 34% inter-programmatic collaborations, and 55% inter-institutional collaboration, with 16% in
high-impact journals. The CPC Program has 27 multi-PI grants, including 6 inter-institutional, 5 intra-
programmatic, 4 inter-programmatic, and 12 with other IU faculty, reflecting strong collaborations through local,
national, and international networking. Leveraging our momentum, the Program will advance the IUSCCC
Strategic Plan through scientific research focused on population health, health risk reduction, predictive
molecular epidemiolog...

## Key facts

- **NIH application ID:** 10934639
- **Project number:** 2P30CA082709-25
- **Recipient organization:** INDIANA UNIVERSITY INDIANAPOLIS
- **Principal Investigator:** Todd C. Skaar
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $68,494
- **Award type:** 2
- **Project period:** 1999-09-22 → 2029-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10934639

## Citation

> US National Institutes of Health, RePORTER application 10934639, Cancer Prevention and Control (2P30CA082709-25). Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/grant/nih/10934639. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*